Bungaro, Maristella
Novello, Silvia
Passiglia, Francesco
Article History
Accepted: 24 October 2022
First Online: 17 November 2022
Declarations
:
: Francesco Passiglia declared advisory/consultant’s fee from Merck Sharp Dohme, Astra Zeneca, Janssen, Amgen, Beigene, and Thermofisher Scientific. Silvia Novello declared speaker bureau/advisor’s fee from Eli Lilly, Merck Sharp Dohme, Roche, BMS, Takeda, Pfizer, Astra Zeneca, Amgen, and Boehringer Ingelheim. The other authors have no conflict to declare.
: This article does not contain any studies with human or animal subjects performed by any of the authors.